Association between hepatic Triglyceride content and left Ventricular Diastolic Function in a Population-based cohort: The Netherlands Epidemiology of Obesity Study1

Radiology

Volumn 279, Issue 2, 2016, Pages 443-450

  Widya, Ralph L ^a   De Mutsert, Renée ^a   Den Heijer, Martin ^a   Le Cessie, Saskia ^a   Rosendaal, Frits R ^a   Wouter Jukema, J ^a   Smit, Johannes W A ^a   De Roos, Albert ^a   Lamb, Hildo J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; HEART LEFT VENTRICLE DIASTOLIC FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HUMAN; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MYOCARDIAL DISEASE; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; DIASTOLE; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

AGED; CROSS-SECTIONAL STUDIES; DIASTOLE; FATTY LIVER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NETHERLANDS; OBESITY; PROSPECTIVE STUDIES; TRIGLYCERIDES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84965164295     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015150035     Document Type: Article

References (33)

1. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004;89(6):2583-2589.
2. Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: An overview. J Gastroenterol Hepatol 2002;17(11):1136-1143.
3. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363(14):1341-1350.
4. Targher G, Bertolini L, Padovani R, et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006;29(6):1325-1330.
5. Lin YC, Lo HM, Chen JD. Sonographic fatty liver, overweight and ischemic heart disease. World J Gastroenterol 2005;11(31):4838-4842.
6. Rijzewijk LJ, Jonker JT, van der Meer RW, et al. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes. J Am Coll Cardiol 2010;56(3):225-233.
7. Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev 2008; 88(2):389-419.
8. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 1997;30(1):8-18.
9. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk: A systematic review and meta-analysis. J Am Coll Cardiol 2010;56(14):1113-1132.
10. Simms MG, Walley KR. Activated macrophages decrease rat cardiac myocyte contractility: importance of ICAM-1-dependent adhesion. Am J Physiol 1999;277(1 Pt 2): H253-H260.
11. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288(2):E462-E468.
12. Pattynama PM, De Roos A, Van der Wall EE, Van Voorthuisen AE. Evaluation of cardiac function with magnetic resonance imaging. Am Heart J 1994;128(3):595-607.
13. Paelinck BP, Lamb HJ, Bax JJ, Van der Wall EE, de Roos A. Assessment of diastolic function by cardiovascular magnetic resonance. Am Heart J 2002;144(2):198-205.
14. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112(17):2735-2752.
15. van der Meer RW, Hammer S, Lamb HJ, et al. Effects of short-term high-fat, highenergy diet on hepatic and myocardial triglyceride content in healthy men. J Clin Endocrinol Metab 2008;93(7):2702-2708.
16. Naressi A, Couturier C, Devos JM, et al. Javabased graphical user interface for the MRUI quantitation package. MAGMA 2001;12(2-3): 141-152.
17. Kim NH, Park J, Kim SH, et al. Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Heart 2014;100(12): 938-943.
18. Fotbolcu H, Yakar T, Duman D, et al. Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. Cardiol J 2010;17(5): 457-463.
19. Goland S, Shimoni S, Zornitzki T, et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol 2006;40(10): 949-955.
20. Fallo F, Dalla Pozza A, Sonino N, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutr Metab Cardiovasc Dis 2009;19(9):646-653.
21. Bonapace S, Perseghin G, Molon G, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 2012;35(2):389-395.
22. Bonora E. The metabolic syndrome and cardiovascular disease. Ann Med 2006;38 (1):64-80.
23. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132(6):2169-2180.
24. Ng AC, Auger D, Delgado V, et al. Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T? mapping and subclinical myocardial dysfunction in diabetic patients: A pilot study. Circ Cardiovasc Imaging 2012;5(1):51-59. [Published correction appears in Circ Cardiovasc Imaging 2012;5(2):e25. ]
25. Perseghin G, Lattuada G, De Cobelli F, et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 2008;47(1):51-58.
26. Ge F, Hu C, Hyodo E, et al. Cardiomyocyte triglyceride accumulation and reduced ventricular function in mice with obesity reflect increased long chain fatty acid uptake and de novo fatty acid synthesis. J Obes 2012; 2012:205648.
27. van Heerebeek L, Hamdani N, Handoko ML, et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008;117(1):43-51.
28. Stefan N, Kantartzis K, Häring HU. Causes and metabolic consequences of fatty liver. Endocr Rev 2008;29(7):939-960.
29. Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008;51(11): 1947-1953.
30. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: The mist gradually clears. J Hepatol 2008;48(Suppl 1):S104-S112.
31. Adams LA, Feldstein AE. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis. J Dig Dis 2011;12(1): 10-16.
32. Idilman IS, Aniktar H, Idilman R, et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 2013;267(3):767-775.
33. Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1. 5 T. Radiology 2009;251(1):67-76.